美股
Lead report
Sonoma Pharmaceuticals Earnings: Revenue of $5.56 Million but EPS Loss of $0.33, Market Eyes Profitability Outlook
Sonoma Pharmaceuticals reported a GAAP loss of $0.33 per share on revenue of $5.56 million. The analysis covers cost control, industry competition, and future turnaround strategies, with investors focused on cash flow and pipeline progress.
